Cargando…

Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis

INTRODUCTION: Adalimumab and etanercept are drugs used in anti-TNF therapy in patients with psoriasis and psoriatic arthritis. Despite the molecular targeting of these drugs, the loss of pharmacological response to treatment is observed in patients. The development of personalized medicine makes it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Swinarew, Andrzej S., Rozwadowska, Beata, Zmarzły, Nikola, Gola, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262816/ https://www.ncbi.nlm.nih.gov/pubmed/32489364 http://dx.doi.org/10.5114/ada.2020.94847

Ejemplares similares

Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020)

The comparison of effectiveness of therapy with ustekinumab and etanercept in psoriatic patients during 48 weeks’ observation
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2021)

Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2018)

Effect of adalimumab on the expression of genes encoding TNF-α signal paths in skin fibroblasts in vitro
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2018)

The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis – preliminary report
por: Krawczyk, Agata, et al.
Publicado: (2021)

In silico analysis of CpG islands and miRNAs potentially regulating the JAK-STAT signalling pathway
por: Grabarek, Beniamin O., et al.
Publicado: (2020)

Differences in expression of genes related to drug resistance and miRNAs regulating their expression in skin fibroblasts exposed to adalimumab and cyclosporine A
por: Grabarek, Beniamin, et al.
Publicado: (2020)

Ustekinumab therapy changes the transcriptional activity pattern of TGF-β1–3 genes
por: Grabarek, Beniamin, et al.
Publicado: (2020)

Variances in the mRNA expression profile of TGF-β1–3 isoforms and its TGF-βRI–III receptors during cyclosporin a treatment of psoriatic patients
por: Michalska-Bańkowska, Anna, et al.
Publicado: (2018)

Seborrhoeic dermatitis and a herpes zoster infection developed during treatment with adalimumab due to Crohn's disease
por: Bergler-Czop, Beata, et al.
Publicado: (2015)

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
por: Bonafede, Machaon, et al.
Publicado: (2013)

Interplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial Cancer
por: Hermyt, Ewelina, et al.
Publicado: (2019)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
por: Mease, P J, et al.
Publicado: (2008)

Madelung's disease in a patient with chronic renal insufficiency: a case report and review of literature
por: Bergler-Czop, Beata, et al.
Publicado: (2014)

Pregnancy: a therapeutic dilemma
por: Brzezińska-Wcisło, Ligia, et al.
Publicado: (2017)

Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes
por: Pfeifer, Emily C., et al.
Publicado: (2017)

Expression of genes related to inflammation – IL-6, IL-8, and IFN-γ in monitoring ustekinumab therapy: preliminary results
por: Kruszniewska-Rajs, Celina, et al.
Publicado: (2022)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
por: Gholami, Ahmad, et al.
Publicado: (2021)

Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis
por: Bednarczyk, Martyna, et al.
Publicado: (2018)

Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer
por: Boroń, Dariusz, et al.
Publicado: (2021)

Recent Multiomics Approaches in Endometrial Cancer
por: Boroń, Dariusz, et al.
Publicado: (2022)

Extensive phlegmon and pyoderma gangrenosum: diagnostic difficulties
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2015)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch, Dario, et al.
Publicado: (2014)

A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis
por: Bukiej, Aleksandra
Publicado: (2020)

New aspects of the treatment of alopecia areata
por: Brzezińska-Wcisło, Ligia, et al.
Publicado: (2014)

Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis
por: Ruano, Juan, et al.
Publicado: (2013)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis
por: Paoletti, Audrey, et al.
Publicado: (2022)

Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis
por: Szeremeta, Anna, et al.
Publicado: (2023)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

Hair diseases: a big problem on a small surface
por: Brzezińska-Wcisło, Ligia A., et al.
Publicado: (2016)

Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy
por: Wu, Keng-Yi, et al.
Publicado: (2015)

Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

miRNAs in the Expression Regulation of Dopamine-Related Genes and Proteins in Endometrial Cancer
por: Czerwiński, Michał, et al.
Publicado: (2021)

Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer
por: Czerwiński, Michał, et al.
Publicado: (2021)

Factors affecting the concentration of soluble tumour necrosis factor-α receptor type I in the blood serum of patients with localized scleroderma
por: Zbiciak-Nylec, Martyna, et al.
Publicado: (2020)

Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment
por: Strand, Vibeke, et al.
Publicado: (2012)

Mitogen-activated kinases in psoriatic arthritis: differences in activation and distinct regulation by etanercept therapy
por: Lories, RJU, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_72oijnr4uupio102d3p77o7cac